Launched in 2001, Bioaxis is now one of the fastest growing healthcare service providers in Europe and beyond. By using unique technologies and partnering with the biggest pharmaceutical companies in the world, Bioaxis is poised for greater expansion-driven growth in the years to come.
With constant feedback from top, in-house healthcare professionals, Bioaxis designs, develops and implements advanced systems for patient adherence programs with real-time data reporting. The company is thereby able to provide the perfect set of services for flexible and customized patient adherence programs. Leveraging its unique, proprietary software, Bioaxis uses its PCP-Patient Compliance Protocol technology to promote better patient care outcomes. The PCP protocol manages all essential actions for a patient adherence program, providing patients a comprehensive overview of their treatment, while also offering accurate, round-the-clock live data.
On The Path Of Hippocrates
Bioaxis’ mission is to provide high quality care for the patient while enhancing overall community care. Through this belief, Bioaxis developed the Drug Refill Service, becoming the sole service provider for transferring drugs to patients who need them—all across Greece.
In Collaboration With The Best
In an effort to provide the world’s best medical assistance for its customers, Bioaxis has chosen to partner with some of the largest and most advanced pharmaceutical companies around the world, including Pfizer, Sanofi – Aventis, Abbott Laboratories and many others.
Number of Employees
Markets Where Bioaxis Is Active
United Kingdom, Greece, Poland, Portugal, Serbia, Bulgaria
Why Bioaxis is Successful
Bioaxis’ secret of success can be found in its high standard of services, its ability to adjust to changing environments, and its devoted personnel consisting of healthcare professionals.
The Innovative Edge
Bioaxis takes full advantage of the latest technological inventions in the field of healthcare in order to ensure that patients will have the best treatment possible.
Bioaxis had to successfully overcome an unstable business environment in Greece to get to where it is today. The company’s leadership notes that operating dynamically and constantly adapting to changes were essential to its success.
Goals for 2013
Following an extremely successful decade, Bioaxis aims at expanding internationally and entering all possible markets.
Bioaxis Is Currently Looking For
Investors, subsidiaries and affiliates